Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways

被引:91
作者
Coulouarn, Cedric [2 ]
Cavard, Catherine [1 ,3 ]
Rubbia-Brandt, Laura [4 ]
Audebourg, Anne [5 ]
Dumont, Florent [1 ,3 ]
Jacques, Sebastien [1 ,3 ]
Just, Pierre-Alexandre [1 ,3 ]
Clement, Bruno [2 ]
Gilgenkrantz, Helene [1 ,3 ]
Perret, Christine [1 ,3 ]
Terris, Benoit [1 ,3 ,5 ]
机构
[1] INSERM, Inst Cochin, U1016, F-75654 Paris 13, France
[2] Univ Rennes 1, INSERM, UMR991, Rennes, France
[3] CNRS, UMR8104, F-75700 Paris, France
[4] Hop Cantonal Univ Geneva, Serv Pathol Clin, CH-1211 Geneva, Switzerland
[5] Univ Paris 05, Hop Cochin, AP HP, Serv Anat & Cytol Pathol, Paris, France
关键词
CARCINOMA; EXPRESSION; LIVER; CELLS; CLASSIFICATION; SURVIVAL; TARGETS; GROWTH; CANCER;
D O I
10.1093/carcin/bgs208
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intrahepatic malignant tumours include hepatocellular carcinomas (HCC), cholangiocarcinomas (CC) and combined hepatocholangiocarcinomas (cHCC-CC), a group of rare and poorly characterized tumours that exhibit both biliary and hepatocytic differentiation. The aim of the study was to characterize the molecular pathways specifically associated with cHCC-CC pathogenesis. We performed a genome-wide transcriptional analysis of 20 histologically defined cHCC-CC and compared them with a series of typical HCC and of CC. Data were analysed by gene set enrichment and integrative genomics and results were further validated in situ by tissue microarray using an independent series of 152 tumours. We report that cHCC-CC exhibit stem/progenitor features, a down-regulation of the hepatocyte differentiation program and a commitment to the biliary lineage. TGF and Wnt/-catenin were identified as the two major signalling pathways activated in cHCC-CC. A -catenin signature distinct from that observed in well-differentiated HCC with mutant -catenin was found in cHCC-CC. This signature was associated with microenvironment remodelling and TGF activation. Furthermore, integrative genomics revealed that cHCC-CC share characteristics of poorly differentiated HCC with stem cell traits and poor prognosis. The common traits displayed by CC, cHCC-CC and some HCC suggest that these tumours could originate from stem/progenitor cell(s) and raised the hypothesis of a potential continuum between intrahepatic CC, cHCC-CC and poorly differentiated HCC.
引用
收藏
页码:1791 / 1796
页数:6
相关论文
共 24 条
  • [1] Cholestasis is a marker for hepatocellular carcinomas displaying β-catenin mutations
    Audard, V.
    Grimber, G.
    Elie, C.
    Radenen, B.
    Audebourg, A.
    Letourneur, F.
    Soubrane, O.
    Vacher-Lavenu, M-C
    Perret, C.
    Cavard, C.
    Terris, B.
    [J]. JOURNAL OF PATHOLOGY, 2007, 212 (03) : 345 - 352
  • [2] An algorithm for the grading of activity in chronic hepatitis C
    Bedossa, P
    Poynard, T
    [J]. HEPATOLOGY, 1996, 24 (02) : 289 - 293
  • [3] Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
    Boyault, Sandrine
    Rickman, David S.
    de Reynies, Aurelien
    Balabaud, Charles
    Rebouissou, Sandra
    Jeannot, Emmanuelle
    Herault, Aurelie
    Saric, Jean
    Belghiti, Jacques
    Franco, Dominique
    Bioulac-Sage, Paulette
    Laurent-Puig, Pierre
    Zucman-Rossi, Jessica
    [J]. HEPATOLOGY, 2007, 45 (01) : 42 - 52
  • [4] New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
    Cadoret, A
    Ovejero, C
    Terris, B
    Souil, E
    Lévy, L
    Lamers, WH
    Kitajewski, J
    Kahn, A
    Perret, C
    [J]. ONCOGENE, 2002, 21 (54) : 8293 - 8301
  • [5] Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas
    Cazals-Hatem, D
    Rebouissou, S
    Bioulac-Sage, P
    Bluteau, O
    Blanché, H
    Franco, D
    Monges, G
    Belghiti, J
    Cunha, AS
    Laurent-Puig, P
    Degott, C
    Zucman-Rossi, J
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (02) : 292 - 298
  • [6] Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
    Coulouarn, C.
    Factor, V. M.
    Andersen, J. B.
    Durkin, M. E.
    Thorgeirsson, S. S.
    [J]. ONCOGENE, 2009, 28 (40) : 3526 - 3536
  • [7] Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
    Coulouarn, Cedric
    Factor, Valentina M.
    Thorgeirsson, Snorri S.
    [J]. HEPATOLOGY, 2008, 47 (06) : 2059 - 2067
  • [8] Stabilization of β-catenin affects mouse embryonic liver growth and hepatoblast fate
    Decaens, Thomas
    Godard, Cecile
    de Reynies, Aurelien
    Rickman, David S.
    Tronche, Francois
    Couty, Jean-Pierre
    Perret, Christine
    Colnot, Sabine
    [J]. HEPATOLOGY, 2008, 47 (01) : 247 - 258
  • [9] EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
  • [10] 2-E